Sociedad Americana de Hirudoterapia

A comparison of outcomes between finger and pulp replantation/revascularization

Systematic review published in Plast Reconstr Surg Glob Open (2023)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportEnsayos clínicosDuah-Asante et al. · Plastic and reconstructive surgery. Global open, 2023

Abstract

UNLABELLED: Supermicrosurgery has allowed the replantation/revascularization of the pulp, but how does this currently compare with more proximal digit replantation/revascularization? METHODS: In a retrospective case study over a 5-year period at our institute, a total of 21 patients (n = 21) had either finger or pulp replantation-revascularization posttrauma. All pulp replants had a single-vessel anastomosis viz., "artery-to-artery" or "artery-to-vein" only, with venous outflow dependent on the skin-shave technique, while more proximal replants had both arterial and venous anastomoses. Age, sex, ischemic time, handedness, smoker status, and injury-replant interval were compared between the two groups, with all procedures performed by a single surgeon. The outcome parameters studied were length of hospital stay, timeline for wound healing, viability, and functional outcomes. RESULTS: Our patients consisted of 18 men and three women, of which 14.3% were smokers and 85.7% were right-handed. There were 11 finger replantation/revascularizations (n = 11) versus 10 pulp replantation/revascularizations (n = 10). The average age of digit replantation/revascularization patients was 44.8 years compared with 26.4 years in pulp replantation/revascularization patients (Student t test, P = 0.04). Mean ischemia time in digital replants was 67 minutes versus 32.3 minutes in pulp replantation/revascularization (Student t test, P = 0.056). Digital replantation/revascularization was viable in 72% of cases versus a 90% viability in the pulp subcohort. CONCLUSIONS: In our patient cohort, pulp replantation/revascularizations produced better postoperative viability. Where supermicrosurgery expertise is available, pulp replantation/revascularization should be considered a worthwhile option when compared with digital replantation/revascularization.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Resumen

Systematic review comparing finger versus pulp replantation/revascularization outcomes.

Por qué esto importa para la hirudoterapia

This retrospective case study compared outcomes between finger and pulp replantation/revascularization in 21 patients, finding that pulp replantation had higher viability (90% vs. 72%) despite single-vessel anastomosis and shorter ischemia time. For ASH's domain, the relevance is indirect—digital replantation is a context where leech therapy may be used to manage postoperative venous congestion—but the abstract does not mention leeches, hirudotherapy, or the leech secretome. The study focuses on surgical outcomes and supermicrosurgical technique. This article offers no direct evidence for or against any aspect of leech therapy.

Citación

A comparison of outcomes between finger and pulp replantation/revascularization.

Duah-Asante et al. · Plastic and reconstructive surgery. Global open, 2023

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.